Pharmacologic aspects of the chemotherapy of solid tumors.
D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003609:Dactinomycin / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D006834:Hydrazines; D011743:Pyrimidines; D003609:Dactinomycin; D014750:Vincristine; D014747:Vinblastine